GeneDx Holdings Corp. (WGS): Free Cash Flow
$14.26M
Year ended 2025-12-31
-$75.80M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $14.26M | n/m | 2026-02-23, From 2025-01-01 |
| 2024-12-31 | -$33.99M | n/m | 2026-02-23, From 2024-01-01 |
| 2023-12-31 | -$185.40M | n/m | 2026-02-23, From 2023-01-01 |
| 2022-12-31 | -$326.31M | n/m | 2024-02-23, From 2022-01-01 |
| 2021-12-31 | -$199.83M | n/m | 2023-03-16, From 2021-01-01 |
| 2020-12-31 | -$117.22M | n/m | 2023-03-16, From 2020-01-01 |
| 2019-12-31 | -$30.65M | n/a | 2022-03-14, From 2019-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | 2025-12-31 | $14.26M | n/m |
| DocGo Inc. (DCGO) | 2025-12-31 | $29.91M | -55.0% |
| Omada Health, Inc. (OMDA) | 2025-12-31 | $16.93M | n/m |
| U S Physical Therapy Inc (USPH) | 2025-12-31 | $60.99M | -7.2% |
| Strata Critical Medical, Inc. (SRTA) | 2025-12-31 | -$58.51M | n/m |
| Pennant Group, Inc. (PNTG) | 2025-12-31 | $36.26M | +19.6% |
| InnovAge Holding Corp. (INNV) | 2026-06-30 | $50.41M | +89.5% |
| LifeStance Health Group, Inc. (LFST) | 2025-12-31 | $110.03M | +28.4% |
| P3 Health Partners Inc. (PIII) | 2024-12-31 | -$110.13M | n/m |
Compare WGS, DCGO, OMDA, USPH side by side · Screen every company in Services-Health Services ↗